Press release
Global Genitourinary Market Estimated to Surpass US$ 30 Billion, Globally, by 2025
The continuous increase in the prevalence of genitourinary disorders across the globe stimulates the market growth significantly. In addition, rising research and development activities coupled with a vast array of pipeline drugs with a high probability of regulatory approval is anticipated to be a high impact growth rendering driver for this industry. However, patient expiry and the influx of generic therapeutics pull back the industry growth to some extent. Companies namely GlaxoSmithKline, Bayer, Abbott, Roche, and Novartis are actively operating in this market. The industry is characterized by the presence of multinational companies as well as the presence of small players is noticeable too. For instance, in February 2017, Argos Therapeutics participated in 2017 Genitourinary Cancers Symposium cosponsored by the American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO), and Society of Urologic Oncology (SUO). The company aimed to present its product offering among the investors through such participation.
To request free sample copy:
www.analystviewmarketinsights.com/request_sample/av127/
Key Takeaways:
• Of the different indications, prostate cancer constitutes the largest share. In 2017, this segment has recorded USD 7.38 billion revenue i.e. over 25% share of the total market
• Availability of wide range of effective therapeutics such as radiopharmaceuticals, anti-neoplastic agents and immunotherapy that can impede disease progression and heightened survival chances, support the segment growth.
• Furthermore, the introduction of advanced formulation techniques by key players’ drive the prostate cancer segment to great extent. For instance, the launch of Xofigo (Radium-223) to treat advanced prostate cancer.
• Renal cancer is considered to be the second largest revenue generating segment owing to the increasing incidences of this disease. According to the World Health Organization (WHO), urinary tract infection is the leading cause of morbidity and healthcare expenditure in patients of all age groups.
• Genitourinary conditions such as interstitial cystitis and bladder cancer are projected to grow with a lucrative CAGR over the forecast period
• Based on products, urological and hormonal therapy captured the highest revenue share due to its high efficiency and cost-effectiveness. In 2017, these segments accounted for more than 50% revenue share collectively.
• Additionally, strong demand for these segment is backed by growing demand for therapeutics such as Edex(Urological), Myrbetriq (Urological), Lupron(Hormonal drug), Xtandi(Hormonal drug) and Zytiga(Hormonal drug)
• Regionally, North America dominated the global industry with 42.6% share in 2017. Increasing prevalence of genitourinary diseases coupled with favorable government initiatives augments the regional development.
Browse full report with in-depth ToC on “Genitourinary Therapeutics Market, By Indication (Prostate Cancer, Benign Prostatic Hyperplasia, Ovarian Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Incontinence & Overactive Bladder, and STD), By Products, And Geography (NA, EU, APAC, And RoW) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” at
www.analystviewmarketinsights.com/report-highlight-genitourinary-therapeutics-market-127/
The scope of this report covers the market by its major segments, as follows: Market, by indication: Prostate Cancer, Benign Prostatic Hyperplasia, Ovarian Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Incontinence & Overactive Bladder, and Sexually Transmitted Diseases; Market, by products: Anti-Infective, Urological, and Hormonal Therapy Drugs;
Market, by Region: North America, Europe, Asia Pacific, Latin America, Middle East and Africa and Rest of the World; Market, by Country: U.S., Canada, Germany, France, India, and China; Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
GlaxoSmithKline
Bayer AG
Pfizer, Inc.
Roche
Abbott
Novartis AG
Bristol-Myers Squibb Company
Antares Pharma
Key benefits of the report:
• The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• A thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of the region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments
Find out more by getting in touch: https://www.analystviewmarketinsights.com/get-in-touch/
About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.
Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Genitourinary Market Estimated to Surpass US$ 30 Billion, Globally, by 2025 here
News-ID: 1262414 • Views: …
More Releases from AnalystView Market Insights
Electric Vehicle Charging Stations Market : New Developments helps to grow marke …
According to latest study by AnalystView Market Insights provides the current status, and projected growth over the next five to ten years. Key topics addressed include market dynamics of the global Electric Vehicle Charging Stations market, projected industry revenue, average product pricing, among others. With industry-standard accuracy in analysis and high data integrity, the reports from AnalystView Market Insights make a brilliant attempt to unveil key opportunities available to help…
Radio Frequency Identification Technology Market Size, Share, Trend, Opportunity …
AnalystView Market Insights recently introduced an in-depth study on Global Radio Frequency Identification Technology market, describing different products and application area which elaborates market outlook and status to 2025.
According to this study, by the end of 2025, the global Radio Frequency Identification Technology market is anticipated to reach USD 41.6 billion, growing at the growth rate of 15.1%. This proposed study provides a comprehensive analysis of radio frequency identification technology…
Proteomics Market Research Report; Explores Market Trends, Size and Future Growt …
New in-depth comprehensive study on “Global Proteomics Market” report has been added AnalystView’s report store. The report aims to describe about different products, application and technology which elaborates market outlook and status to 2025.
According to this study, the global Proteomics market is expected to grow at growth rate of 10.2% to reach USD 25.3 billion by 2025.This proposed study provides comprehensive analysis based on industry’s growth potential, market drivers, barriers,…
Global Industrial Robotics Market: Articulated Robots Continue to Hold a Major S …
According to this study, Industrial Robotics market size to keep up the strong yearly development rate of 5.3% from USD 32.7 billion in 2017 to 2025. Trust that in the following couple of years, the industry’s showcase size will be extended, we expect that the market size will achieve 49.8 billion by the end of 2025. This industry analysis is a cumulative effort of paid primary interviews through paid data…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
